The Human Egg Sellers

What It Covers

NPR's Dia Hadid and Shweta Desai investigate India's underground egg-selling market, nine months in the making, tracing how impoverished women sell eggs through chains of agents and clinics after India's 2021 Assisted Reproductive Technology Act banned compensation, creating a black market affecting thousands of vulnerable women across Chennai, Mumbai, and Varanasi.

Key Questions Answered

• •Regulatory backfire: India's 2021 ART Act, intended to protect women from exploitation, instead drove the fertility industry underground. Of nearly 8,600 fertility clinics and egg banks operating in India, fewer than 3,200 — under 40% — are registered. Unregistered clinics face no oversight, leaving egg sellers with zero legal recourse if harmed or cheated.
• •Payment disparity by class: A two-tier market operates openly. "Premium" donors — models and actresses with light skin and education — receive $3,000–$7,000 per retrieval, sometimes flown to Kenya or Bangkok. Impoverished women from lower-caste slums receive roughly $300 per cycle, equivalent to three months' factory wages, with no medical follow-up guaranteed.
• •Agent network structure: Fertility clinics insulate themselves legally by routing payments through female agents recruited via WhatsApp. Agents earn $50–$100 per donor placed, passing the remainder on. This structure allows clinics to claim they pay agents, not women directly for eggs, creating deliberate legal ambiguity that shields clinics from accountability under the ART law.
• •Repeated extraction health risks: Women like "H" report undergoing egg retrieval at least 30 times. Repeated hormonal stimulation carries documented risks including ovarian hyperstimulation syndrome, ranging from bloating to respiratory distress. Two deaths post-stimulation were recorded in medical journals since 2021, yet no national data collection or mandatory reporting system exists for adverse outcomes in this population.
• •Minor exploitation gap: A 13-year-old girl in Varanasi was recruited by a neighbor and had her eggs extracted at a Nova IVF franchise clinic — one of India's largest fertility chains. Nova attributed screening responsibility to a third-party company. India's ART regulatory board members, when interviewed, stated they were entirely unaware this underground market had emerged at this scale.